Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma

BACKGROUND: Improving outcomes of patients with glioblastoma (GBM) represents a significant challenge in neuro-oncology. We undertook a systematic review of key parameters of phase II and III trials in GBM to identify and quantify the impact of trial design on this phenomenon. METHODS: Studies betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Balasubramanian, Adithya, Gunjur, Ashray, Hafeez, Umbreen, Menon, Siddharth, Cher, Lawrence M, Parakh, Sagun, Gan, Hui Kong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850118/
https://www.ncbi.nlm.nih.gov/pubmed/33543145
http://dx.doi.org/10.1093/noajnl/vdaa171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850118/
https://www.ncbi.nlm.nih.gov/pubmed/33543145
http://dx.doi.org/10.1093/noajnl/vdaa171

Ejemplares similares